News

Gilead in-licenses MicroDose Therapeutx’ MDT-637 for RSV; posts 1st-qtr results

21-04-2011

Gilead Sciences (Nasdaq: GILD) and MicroDose Therapeutx have entered into an exclusive worldwide license…

FinancialGilead SciencesLicensingMicroDose TherapeutxPharmaceuticalResearchRespiratory and Pulmonary

Back to top